Katie Reuther on The Future of Penn Health-Tech and Penn’s Thriving Innovation Ecosystem
Penn Health-Tech is well known for turning innovative ideas across the health system into useful technologies and products that solve problems and advance health care.
Penn Gene-Editing Spinout iEcure Receives Rare Pediatric Disease Designation from FDA for Lead Drug Candidate
iEcure is developing the new drug candidate, GTP-506, as a treatment for a rare genetic condition caused by a genetic defect in a liver enzyme responsible for detoxification of ammonia.
Carl June Discusses Applications of CAR-T Cell Therapy in Science Friday Interview
In this Science Friday interview, Dr. Carl June discusses CAR-T's continued use in battling new blood cancers, as well as its future potential for treating solid state cancers and autoimmune diseases.
New Applications for Teeth-Cleaning Microrobots, including Dental Treatment and Diagnostics
A proof-of-concept study has shown that these microrobots can also access the difficult-to-reach surfaces of the root canal with controlled precision.
Tech of the Month: Penn Faculty Invent Superlattices of Atomically Thin Materials with Strong Light Absorption for Next-Generation Optical Devices
A team of researchers led by Dr. Deep Jariwala recently developed superlattices that offer controllable thickness, device-scale lateral size, and strong light absorption.
President’s Innovation Prize Winner Lumify Care and PCI Startup Neuralert Hit Major Milestones in 2022
Lumify Care and Neuralert have grown rapidly in terms of funding and product expansion.
Penn Graduate Receives President’s Sustainability Prize for Robotics-Based System to Minimize Waste in Fishing Industry
Shinkei Systems cuts down on waste by reducing the likelihood that off-target species would be caught and killed, and streamlining the process to avoid waste.
New Penn Dental School Study Identifies Protein that Can Potentially Keep Bone Loss in Check
The research identifies the protein IFT80 as a key player in regulating populations of osteoclasts, cells that break down bone.
Penn Research on Chewing Gum that Could Reduce SARS-CoV-2 Transmission Enters Clinical Trial
Researchers are preparing to launch the first human trial to see how the gum affects active COVID-19 patients.
Penn-invented CAR-T Therapy Earns the Word ‘Cure’
"We have a couple dozen patients who are 5, 6, 7, 9 years out or more without further therapy. That feels like a cure to me."